Chromosomal microarray (CMA) plays a significant role in Oncology research where whole‑genome sequencing or whole‑exome sequencing are not yet offered as routine tests, or when next‑generation sequencing (NGS) panels provide limited or inconclusive results.

In this webinar, Dr. Madina Sukhanova demonstrates the utility of CMA combined with NGS assays to identify and research genetic aberrations associated with specific prognoses in different types of cancer.

Learning objectives include:

• Learn how to investigate interesting oncology cases and findings
• Gain working knowledge of the importance of CMA and how it plays a vital role in oncology research
• Discover the utility of CMA combined with NGS